ABRAXANE

Abraxis BioScience, LLC🇺🇸 United States

FDA Page

Effective Date: Oct 31, 2022
Approval ID: 24d10449-2936-4cd3-b7db-a7683db721e4
Products: 1 registered
Version: 37

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE. ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension)(albumin-bound), for intravenous use Initial U.S. Approval: 2005

Quick Stats

Total Products1

Labelers2

Label Sections44

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.